首页> 外文期刊>The Internet Journal of Nephrology >Dyslipidemia: End Stage Renal Disease and Hemodialysis
【24h】

Dyslipidemia: End Stage Renal Disease and Hemodialysis

机译:血脂异常:终末期肾脏疾病和血液透析

获取原文
           

摘要

Chronic renal failure (CRF) is a pro-oxidant state and the degree of intracellular and extracellular oxidative stress is related to the severity of renal failure. The present study was taken up to evaluate Dyslipidemia in patients undergoing hemodialysis session. In our study, the hemodialysis patients were found to have Dyslipidemia as evidenced by HD can moderately attenuate the renal dyslipidemia. Accumulation of atherogenic lipoproteins could also play a role in the development of atherosclerotic complications in HD patients. This Dyslipidemia plays an important role in the development of atherosclerosis in hemodialysis
机译:慢性肾衰竭(CRF)是一种促氧化剂状态,细胞内和细胞外氧化应激的程度与肾衰竭的严重程度有关。本研究用于评估血液透析患者的血脂异常。在我们的研究中,血液透析患者被发现患有血脂异常,HD可以适当减轻肾血脂异常。动脉粥样硬化性脂蛋白的积累也可能在HD患者的动脉粥样硬化并发症的发展中发挥作用。血脂异常在血液透析的动脉粥样硬化发展中起重要作用

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号